Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Large Growth in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 114,200 shares, a growth of 275.7% from the November 30th total of 30,400 shares. Currently, 27.0% of the shares of the stock are short sold. Based on an average trading volume of 1,420,000 shares, the short-interest ratio is presently 0.1 days.

Avalon GloboCare Stock Performance

Shares of ALBT traded down $0.26 during trading hours on Friday, reaching $3.29. The stock had a trading volume of 243,566 shares, compared to its average volume of 497,828. Avalon GloboCare has a 12 month low of $2.11 and a 12 month high of $21.60. The stock has a market capitalization of $3.60 million, a PE ratio of -0.16 and a beta of 0.27. The company’s 50-day moving average is $3.25 and its two-hundred day moving average is $4.44.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.